FDA Approved
Showing 1 - 25 of >10,000
Cataract Trial in San José (Omega Refractive Capsule with FDA approved Intraocular Lens, FDA approved Intraocular lens)
Completed
- Cataract
- Omega Refractive Capsule with FDA approved Intraocular Lens
- FDA approved Intraocular lens
-
San José, Costa RicaClinica 20/20
Apr 18, 2022
Mobile Applications, Healthy Volunteers, Feasibility Study Trial in Saint Louis (Investigational Mobile Medical Software
Completed
- Mobile Applications
- +2 more
- Investigational Mobile Medical Software Application & IT Dashboard Application, FDA approved Bluetooth spirometer, FDA approved pulse oximeter
-
Saint Louis, MissouriWashington University in St. Louis
Dec 21, 2022
ADHD Trial (FDA approved medications for ADHD plus Quantitative EEG Neurofeedback, FDA approved medications for ADHD)
Not yet recruiting
- ADHD
- FDA approved medications for ADHD plus Quantitative EEG Neurofeedback
- FDA approved medications for ADHD
- (no location specified)
Nov 23, 2022
Cataract Trial in San José (Omega Refractive Capsule with an FDA approved Intraocular Lens, FDA approved Intraocular Lens)
Active, not recruiting
- Cataract
- Omega Refractive Capsule with an FDA approved Intraocular Lens
- FDA approved Intraocular Lens
-
San José, Costa RicaClinica 20/20
Jun 14, 2022
Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Afrezza
- +3 more
- (no location specified)
Jun 6, 2023
Surgical Wound, Upper Extremity Injury Trial in Atlanta (Monocryl (FDA Approved) buried running, Monocryl buried interrupted,
Not yet recruiting
- Surgical Wound
- Upper Extremity Injury
- Monocryl (FDA Approved) buried running
- +6 more
-
Atlanta, Georgia
- +2 more
Jul 6, 2022
Patent Foramen Ovale, Cryptogenic Stroke Trial (Encore PFO closure device, FDA-approved PFO closure device)
Not yet recruiting
- Patent Foramen Ovale
- Cryptogenic Stroke
- Encore PFO closure device
- FDA-approved PFO closure device
- (no location specified)
Sep 8, 2022
Coronary Artery Disease Trial in Washington (PCI with SELUTION SLR DCB, PCI with FDA approved "-limus" DES)
Not yet recruiting
- Coronary Artery Disease
- PCI with SELUTION SLR DCB
- PCI with FDA approved "-limus" DES
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Jul 7, 2023
Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- combinations of up to 3 FDA approved drugs from a panel of compounds
- (no location specified)
Jan 19, 2023
Carpal Tunnel Syndrome Trial in Scottsdale, Rochester (FDA approved ultrasound system with shear wave elastography capability)
Enrolling by invitation
- Carpal Tunnel Syndrome
- FDA approved ultrasound system with shear wave elastography capability
-
Scottsdale, Arizona
- +1 more
Jan 10, 2023
Varicose Veins Trial (Varithena®, FDA-approved Endothermal Ablation (ETA) systems)
Not yet recruiting
- Varicose Veins
- Varithena®
- FDA-approved Endothermal Ablation (ETA) systems
- (no location specified)
Jul 24, 2022
Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)
Not yet recruiting
- Primary Membranous Nephropathy
- SNP-ACTH (1-39) Gel
- Rituximab
- (no location specified)
Jan 13, 2023
Skin Manifestations Trial in West Palm Beach, New Orleans, Cincinnati (GP0116, Active Comparator: FDA approved dermal filler
Active, not recruiting
- Skin Manifestations
- GP0116
- Active Comparator: FDA approved dermal filler device
-
West Palm Beach, Florida
- +2 more
Aug 9, 2023
POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved
Not yet recruiting
- Covid19
- Covid-19 test
- (no location specified)
Jul 27, 2021
Immunization, HPV Infection, Human Papillomavirus Trial in Galveston (9-valent HPV vaccine, 2 doses alternate timing, 9-valent
Recruiting
- Immunization
- +2 more
- 9-valent HPV vaccine, 2 doses alternate timing
- 9-valent HPV vaccine, 3 doses standard timing
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 30, 2023
Glaucoma, Open-Angle, Ocular Hypertension Trial in Winston-Salem (Brinzolamide/brimonidine ophthalmic suspension, Simbrinza
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- Brinzolamide/brimonidine ophthalmic suspension
- Simbrinza 0.2%/1% Ophthalmic Suspension
-
Winston-Salem, North CarolinaJames D. Branch Ophthalmology
Aug 18, 2022
AAA, AAA - Abdominal Aortic Aneurysm Trial (Alto Abdominal Stent Graft System, FDA Approved EVAR AAA Graft Systems)
Not yet recruiting
- AAA
- AAA - Abdominal Aortic Aneurysm
- Alto Abdominal Stent Graft System
- FDA Approved EVAR AAA Graft Systems
- (no location specified)
Jun 3, 2022
Classification of Breast Masses Based on Visco-elastic
Recruiting
- Breast Cancer
- FDA approved GE LOGIQ E9 (LE9) ultrasound
- Alpinion clinical ultrasound machine
-
Rochester, MinnesotaMayo Clinic
Apr 11, 2022
Metastatic Colorectal Cancer Trial in Gainesville (Signatera ctDNA assay, pre-specified sequence of FDA-approved drugs and drug
Recruiting
- Metastatic Colorectal Cancer
- Signatera ctDNA assay
- pre-specified sequence of FDA-approved drugs and drug combinations
-
Gainesville, FloridaUniversity of Florida
Aug 9, 2022
Actinic Keratosis Trial (Ingenol Mebutate (Perrigo), Ingenol Mebutate (Reference), Placebo gel)
Completed
- Actinic Keratosis
- Ingenol Mebutate (Perrigo)
- +2 more
- (no location specified)
Oct 29, 2021
Actinic Keratosis Trial (Ingenol Mebutate (Perrigo), Ingenol Mebutate (Reference), Placebo gel)
Completed
- Actinic Keratosis
- Ingenol Mebutate (Perrigo)
- +2 more
- (no location specified)
Oct 29, 2021
Hypoxic Events Trial (FDA approved pulse oximeter and DOVE device prototype)
Not yet recruiting
- Hypoxic Events
- FDA approved pulse oximeter and DOVE device prototype
- (no location specified)
Jan 19, 2022
Food Allergy, Food Allergy Peanut Trial in Baltimore (Acalabrutinib)
Recruiting
- Food Allergy
- Food Allergy Peanut
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Dec 30, 2021
Blood Pressure Trial in Tel Aviv (CS6BP watches will be used in the study.)
Active, not recruiting
- Blood Pressure
- CS6BP watches will be used in the study.
-
Tel Aviv, IsraelTel Aviv Sourasky Medical Center
May 6, 2022
Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,
Not yet recruiting
- Refractory Non-Hodgkin Lymphoma
- +2 more
- Mosunetuzumab
- +2 more
-
Miami, FloridaUniversity of Miami
Aug 3, 2022